BioDelivery Sciences International, Inc. (BDSI)
-NasdaqCM | Prev Close: | 4.53 |
|---|
| Open: | N/A |
|---|
| Bid: | 4.32 x 400 |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 8.61 |
|---|
| Beta: | 3.24 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 3.52 - 6.89 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 218,738 |
|---|
| Market Cap: | 172.12M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.55 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- BIODELIVERY SCIENCES INTERNATIONAL INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online(Mon, Jun 10)
- BioDelivery Sciences Announces NDA Submission for BUNAVAIL on Track Following Positive Pre-NDA Meeting with FDAPR Newswire(Mon, Jun 10)
- Endo Health to slash 15 pct jobs, looks to sell some assetsat Reuters(Wed, Jun 5)
- BioDelivery Sciences to Present at the William Blair 33rd Annual Growth Stock ConferencePR Newswire(Wed, Jun 5)
- BioDelivery Sciences to Present at the Jefferies 2013 Global Healthcare ConferencePR Newswire(Tue, May 28)
- BioDelivery Sciences Primed To Grab Its Share Of The $1.5 Billion Opioid Marketat Seeking Alpha(Tue, May 28)
- BIODELIVERY SCIENCES INTERNATIONAL INC FinancialsEDGAR Online Financials(Fri, May 17)
- BDSI Makes Notable Cross Below Critical Moving Averageat TheStreet(Fri, May 17)
- BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of First Quarter 2013 FinancialsPR Newswire(Thu, May 9)
- BIODELIVERY SCIENCES INTERNATIONAL INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online(Thu, May 9)
- BIODELIVERY SCIENCES INTERNATIONAL INC Files SEC form 10-Q, Quarterly ReportEDGAR Online(Thu, May 9)
- BioDelivery Sciences to Present at the Bank of America Merrill Lynch 2013 Health Care ConferencePR Newswire(Tue, May 7)
- Hedge Funds Are Buying These 3 Biotech Small Caps Trading Below Lowest Target Priceat Seeking Alpha(Wed, May 1)
- BIODELIVERY SCIENCES INTERNATIONAL INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial StateEDGAR Online(Mon, Apr 29)
- BioDelivery Sciences Appoints Thomas W. D'Alonzo to Board of DirectorsPR Newswire(Mon, Apr 29)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 4.34 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -1.02 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.34 |
|---|
| Mean Recommendation*: | 1.6 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapeutics in the areas of pain management and oncology supportive care.
View More 
1.35%